Rapid hemostasis |
Natural mineral clays |
Zeolite, kaolin, montmorillonite |
Blood absorption, Ca2+ release, negative surface charge, mechanical strength enhancement, tissue adhesive |
121 and 128
|
Silica-based mesoporous particles |
AgCaMSS, CSMS-S, Ga2O3-MBGs, Ta-MBGs, diatom silica |
Blood absorption, high surface aera and pore volume, Ca2+ release, negative surface charge |
135, 138, 143 and 150
|
Inorganic–polymer composites |
Mesoporous single-crystal zeolite, NEM, HNTs, rectorite |
Blood absorption, concentrating coagulation factors, negative surface charge, tissue adhesive, physical barrier |
40, 155, 159 and 165
|
Self-supporting inorganic-based biomaterials |
Graphene, GO, CNTs, ultralong HAP nanowires, hollow Al2O3 fibers |
Blood absorption, super hydrophilicity and hemophilicity, high surface aera, activation of platelets |
36, 38, 150–153, 176 and 178
|
Wound healing |
Basic dressings |
CST5, FS, BP, t-ZnO, CaSiO3, SS |
Bioactive ion release, angiogenesis, PTT, CDT, skin defects regeneration |
194, 201, 203 and 205
|
Therapeutic functional inorganic-based biomaterials |
TiO2-NTs, CaCuSi4O10, HMZS, hollow manganese silicate nanospheres |
Bioactive ion release, antibacterial activity, angiogenesis, skin appendage remolding, hair follicle regeneration |
38, 179, 189, 212 and 215
|
Intelligently responsive inorganic-based biomaterials |
Ag3PO4/MoS2, LAPONITE® RDS, Ti3C2Tx, Fe3O4@SiO2, MoS2 nanosheet |
Antibacterial activity, angiogenesis, pH-responsive, PTT, PDT, controlled drug delivery, electrical stimulation |
232–236
|
Rapid hemostasis and wound healing |
Dual functional inorganic-based biomaterials |
AgNPs, HNTs, CaCO3, ZnO mesocellular silica foam |
Blood absorption, negative surface charge, hemostasis drug release, antibacterial activity, reduce inflammation, promote re-epithelization and collagen deposition |
53, 243, 245 and 246
|
Clot maintaining inorganic-based biomaterials |
AgNP-MSG, MSS@CaCO3T, CuS, Stober silica and iron oxide |
Blood absorption, negative surface charge, tissue adhesive, clot maintaining, antibacterial activity, degradability, bioactive ion release, biocompatibility |
29, 248–250
|